A series of vectors for inducible gene expression in multidrug-resistant Acinetobacter baumannii

被引:0
|
作者
Intorcia, Valerie [1 ]
Sava, Rosa L. [1 ]
Schroeder, Grace P. [1 ]
Gebhardt, Michael J. [1 ]
机构
[1] Univ Iowa, Carver Coll Med, Dept Microbiol & Immunol, Iowa City, IA 52242 USA
关键词
apramycin; hygromycin; gene expression; plasmids; cloning; MINI-TN7; VECTORS; RANGE; CLONING;
D O I
10.1128/aem.00474-24
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The continued emergence of antibiotic resistance among bacterial pathogens remains a significant challenge. Indeed, the enhanced antibiotic resistance profiles of contemporary pathogens often restrict the number of suitable molecular tools that are available. We have constructed a series of plasmids that confer resistance to two infrequently used antibiotics with variants of each plasmid backbone incorporating several regulatory control systems. The regulatory systems include both commonly used systems based on the lac- and arabinose-controlled promoters found in Escherichia coli, as well as less frequently used systems that respond to tetracycline/anhydrotetracycline and toluic acid. As a test case, we demonstrate the utility of these plasmids for regulated and tunable gene expression in a multidrug-resistant (MDR) isolate of Acinetobacter baumannii, strain AB5075-UW. The plasmids include derivatives of a freely replicating, broad-host-range plasmid allowing for inducible gene expression as well as a set of vectors for introducing genetic material at the highly conserved Tn7-attachment site. We also modified a set of CRISPR-interference plasmids for use in MDR organisms, thus allowing researchers to more readily interrogate essential genes in currently circulating clinical isolates. These tools will enhance molecular genetic analyses of bacterial pathogens in situations where existing plasmids cannot be used due to their antibiotic resistance determinants or lack of suitable regulatory control systems.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Multidrug-resistant Acinetobacter baumannii
    Abbo, A
    Navon-Venezia, S
    Orly, HM
    Krichali, T
    Siegman-Igra, Y
    Carmeli, Y
    EMERGING INFECTIOUS DISEASES, 2005, 11 (01) : 22 - 29
  • [2] Multidrug-resistant Acinetobacter baumannii
    Krcmery, Vladimir
    Kalavsky, Erich
    EMERGING INFECTIOUS DISEASES, 2007, 13 (06) : 943 - 944
  • [3] Multidrug-Resistant Acinetobacter baumannii mediastinitis
    Dumani, Selman
    Puca, Edmond
    Likaj, Ermal
    Llazo, Stavri
    Rruci, Edlira
    Beca, Vera
    Refatllari, Ali
    Baboci, Arben
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (07): : 1132 - 1134
  • [4] Multidrug-Resistant Acinetobacter baumannii in Jordan
    Al-Tamimi, Mohammad
    Albalawi, Hadeel
    Alkhawaldeh, Mohamd
    Alazzam, Abdullah
    Ramadan, Hassan
    Altalalwah, Majd
    Alma'aitah, Ahmad
    Al Balawi, Dua'a
    Shalabi, Sharif
    Abu-Raideh, Jumana
    Khasawneh, Ashraf, I
    Alhaj, Farah
    Hijawi, Kamal
    MICROORGANISMS, 2022, 10 (05)
  • [5] Multidrug-resistant Acinetobacter baumannii, Russia
    Naas, Thierry
    Kernbaum, Serge
    Allali, Sophie
    Nordmann, Patrice
    EMERGING INFECTIOUS DISEASES, 2007, 13 (04) : 669 - 671
  • [6] New Shuttle Vectors for Gene Cloning and Expression in Multidrug-Resistant Acinetobacter Species
    Lucidi, Massimiliano
    Runci, Federica
    Rampioni, Giordano
    Frangipani, Emanuela
    Leoni, Livia
    Visca, Paolo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [7] Multidrug-resistant Acinetobacter baumannii: A therapeutic challenge
    Martinez Perez, Maria
    Vazquez Blanquino, Alberto
    Moron, Rocio
    Perez Rodriguez, Lucia
    Chueca Porcuna, Natalia
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2023, 36 (05) : 536 - 538
  • [8] Molecular Surveillance of Multidrug-Resistant Acinetobacter baumannii
    AlAmri, Aisha M.
    AlQurayan, Ameerah M.
    Sebastian, Tunny
    AlNimr, Amani
    CURRENT MICROBIOLOGY, 2020, 77 (03) : 335 - 342
  • [9] Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii
    Li, Jian
    Rayner, Craig R.
    Nation, Roger L.
    Owen, Roxanne J.
    Spelman, Denis
    Tan, Kar Eng
    Liojios, Lisa
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (09) : 2946 - 2950
  • [10] Confronting multidrug-resistant Acinetobacter baumannii: a review
    Neonakis, Ioannis K.
    Spandidos, Demetrios A.
    Petinaki, Efthimia
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (02) : 102 - 109